Operating model centralizing open label products used in Clinical Trials

Comparator supply decisions are becoming increasingly critical to the success of clinical trials — yet they are often made too late. As study designs become more complex and startup timelines tighten, it’s essential to incorporate comparator considerations early — giving them a seat at the study table from the pre-feasibility phase onward